At a glance
- Originator Nihon Schering
- Class Antineoplastics
- Mechanism of Action Alkylating agents; Apoptosis stimulants; DNA cross linking agents; DNA inhibitors; DNA topoisomerase inhibitors; Mitosis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer